Soft-tissue wound healing by anti-advanced glycation end-products agents

Journal of Dental Research

Volumn 93, Issue 4, 2014, Pages 388-393

  Chang, P C ^a,b   Tsai, S C ^c   Jheng, Y H ^a   Lin, Y F ^d   Chen, C C ^d  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d National Science Council   (Taiwan)

Author keywords

free tissue flaps; gene expression; guanidines; thiazoles

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; AMINOGUANIDINE; CELL ADHESION MOLECULE; COLLAGEN; COLLAGEN TYPE 1; FIBRONECTIN; GUANIDINE DERIVATIVE; HEME OXYGENASE; HMOX1 PROTEIN, RAT; IMMUNOGLOBULIN RECEPTOR; N PHENACYL 4,5 DIMETHYLTHIAZOLIUM BROMIDE; N-PHENACYL-4,5-DIMETHYLTHIAZOLIUM BROMIDE; NITRIC OXIDE SYNTHASE; POSTN PROTEIN, RAT; THIAZOLE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

ANIMAL; ARTICLE; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; EPITHELIZATION; FREE-TISSUE FLAPS; GENE EXPRESSION; INFLAMMATION; JAW; MALE; PALATE; PATHOLOGY; RAT; SCAR; SPRAGUE DAWLEY RAT; TIME; WOUND CLOSURE; WOUND HEALING;

FREE-TISSUE FLAPS; GENE EXPRESSION; GUANIDINES; THIAZOLES;

ALVEOLAR PROCESS; ANIMALS; CELL ADHESION MOLECULES; CICATRIX; COLLAGEN; COLLAGEN TYPE I; DOWN-REGULATION; FIBRONECTINS; GLYCOSYLATION END PRODUCTS, ADVANCED; GUANIDINES; HEME OXYGENASE (DECYCLIZING); INFLAMMATION; MALE; NITRIC OXIDE SYNTHASE; PALATE; RATS; RATS, SPRAGUE-DAWLEY; RE-EPITHELIALIZATION; RECEPTORS, IMMUNOLOGIC; THIAZOLES; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND CLOSURE TECHNIQUES; WOUND HEALING;

EID: 84896464410     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034514523785     Document Type: Article

References (31)

1. Abbass MM, Korany NS, Salama AH, Dmytryk JJ, Safiejko-Mroczka B. The relationship between receptor for advanced glycation end products expression and the severity of periodontal disease in the gingiva of diabetic and non diabetic periodontitis patients. Arch Oral Biol. 2012 ; 57: 1342-1354
2. Agudio G, Nieri M, Rotundo R, Cortellini P, Pini Prato G. Free gingival grafts to increase keratinized tissue: a retrospective long-term evaluation (10 to 25 years) of outcomes. J Periodontol. 2008 ; 79: 587-594
3. Bejar J, Peled E, Boss JH. Vasculature deprivation-induced osteonecrosis of the rat femoral head as a model for therapeutic trials. Theor Biol Med Model. 2005 ; 2: 24
4. Chang PC, Chung MC, Wang YP, Chien LY, Lim JC, Liang K, et al. Patterns of diabetic periodontal wound repair: a study using micro-computed tomography and immunohistochemistry. J Periodontol. 2012 ; 83: 644-652
5. Chang PC, Chien LY, Yeo JF, Wang YP, Chung MC, Chong LY, et al. Progression of periodontal destruction and the roles of advanced glycation end products in experimental diabetes. J Periodontol. 2013 ; 84: 379-388
6. Chang PC, Chong LY, Tsai SC, Lim LP. Aminoguanidine inhibits the AGE-RAGE axis to modulate the induction of periodontitis but has limited effects on the progression and recovery of experimental periodontitis: a preliminary study. J Periodontol. 2014a in press ;:
7. Chang PC, Tsai SC, Chong LY, Kao MJ. N-phenacylthiazolium bromide inhibits the AGE-RAGE axis to modulate experimental periodontitis in rats. J Periodontol. 2014b ;:
8. Cooper ME, Thallas V, Forbes J, Scalbert E, Sastra S, Darby I, et al. The cross-link breaker, N-phenacylthiazolium bromide prevents vascular advanced glycation end-product accumulation. Diabetologia. 2000 ; 43: 660-664
9. Di Paola R, Marzocco S, Mazzon E, Dattola F, Rotondo F, Britti D, et al. Effect of aminoguanidine in ligature-induced periodontitis in rats. J Dent Res. 2004 ; 83: 343-348
10. Diegelmann RF, Evans MC. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci. 2004 ; 9: 283-289
11. Engelen L, Stehouwer CD, Schalkwijk CG. Current therapeutic interventions in the glycation pathway: evidence from clinical studies. Diabetes Obes Metab. 2012 ; 15: 677-689
12. Farhad AR, Razavi S, Jahadi S, Saatchi M. Use of aminoguanidine, a selective inducible nitric oxide synthase inhibitor, to evaluate the role of nitric oxide in periapical inflammation. J Oral Sci. 2011 ; 53: 225-230
13. Goh SY, Cooper ME. Clinical review: the role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab. 2008 ; 93: 1143-1152
14. Griffin TJ, Cheung WS, Zavras AI, Damoulis PD. Postoperative complications following gingival augmentation procedures. J Periodontol. 2006 ; 77: 2070-2079
15. Hartog JW, Willemsen S, van Veldhuisen DJ, Posma JL, van Wijk LM, Hummel YM, et al. Effects of alagebrium, an advanced glycation endproduct breaker, on exercise tolerance and cardiac function in patients with chronic heart failure. Eur J Heart Fail. 2011 ; 13: 899-908
16. Kahnberg KE, Thilander H. Healing of experimental excisional wounds in the rat palate. (I) Histological study of the interphase in wound healing after sharp dissection. Int J Oral Surg. 1982 ; 11: 44-51
17. Kopman JA, Kim DM, Rahman SS, Arandia JA, Karimbux NY, Fiorellini JP. Modulating the effects of diabetes on osseointegration with aminoguanidine and doxycycline. J Periodontol. 2005 ; 76: 614-620
18. Lalla E, Lamster IB, Stern DM, Schmidt AM. Receptor for advanced glycation end products, inflammation, and accelerated periodontal disease in diabetes: mechanisms and insights into therapeutic modalities. Ann Periodontol. 2001 ; 6: 113-118
19. Lokmic Z, Musyoka J, Hewitson TD, Darby IA. Hypoxia and hypoxia signaling in tissue repair and fibrosis. Int Rev Cell Mol Biol. 2012 ; 296: 139-185
20. Mealey BL, Oates TW. Diabetes mellitus and periodontal diseases. J Periodontol. 2006 ; 77: 1289-1303
21. Nabers JM. Free gingival grafts. Periodontics. 1966 ; 4: 243-245
22. Nedic O, Rattan SI, Grune T, Trougakos IP. Molecular effects of advanced glycation end products (AGEs) on cell signalling pathways, ageing and pathophysiology. Free Radic Res. 2013 ;: 28-38
23. Rios HF, Ma D, Xie Y, Giannobile WV, Bonewald LF, Conway SJ, et al. Periostin is essential for the integrity and function of the periodontal ligament during occlusal loading in mice. J Periodontol. 2008 ; 79: 1480-1490
24. Silva CO, Ribeiro Edel P, Sallum AW, Tatakis DN. Free gingival grafts: graft shrinkage and donor-site healing in smokers and non-smokers. J Periodontol. 2010 ; 81: 692-701
25. Sorci G, Riuzzi F, Giambanco I, Donato R. RAGE in tissue homeostasis, repair and regeneration. Biochim Biophys Acta. 2013 ; 1833: 101-109
26. Sparvero LJ, Asafu-Adjei D, Kang R, Tang D, Amin N, Im J, et al. RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. J Translational Med. 2009 ; 7: 17
27. Stimmelmayr M, Stangl M, Edelhoff D, Beuer F. Clinical prospective study of a modified technique to extend the keratinized gingiva around implants in combination with ridge augmentation: one-year results. Int J Oral Maxillofac Implants. 2011 ; 26: 1094-1101
28. Wei PC, Laurell L, Geivelis M, Lingen MW, Maddalozzo D. Acellular dermal matrix allografts to achieve increased attached gingiva. Part 1. A clinical study. J Periodontol. 2000 ; 71: 1297-1305
29. Wei Q, Ren X, Jiang Y, Jin H, Liu N, Li J. Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress. BMC Cardiovasc Disord. 2013 ; 13: 13
30. Yan SF, Yan SD, Ramasamy R, Schmidt AM. Tempering the wrath of RAGE: an emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation. Ann Med. 2009 ; 41: 408-422
31. Zhang Q, O'Hearn S, Kavalukas SL, Barbul A. Role of high mobility group box 1 (HMGB1) in wound healing. J Surg Res. 2012 ; 176: 343-347